Evidence map›Paper›PMID 40131356›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2025

Porphyromonas gingivalis outer membrane vesicles divert host innate immunity and promote inflammation via C4' monophosphorylated lipid A.

Stephen R Coats, Thet Hnin Su, Zoe Luderman Miller, Alisa J King, Joshua Ortiz, Angel Reddy, Sarah R Alaei, Sumita Jain

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Deciphering macrophage molecular responses toFrontiers in microbiology · 2026
    Article
  7. Review
  8. Journal of oral microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Stephen R CoatsDepartment of Periodontics, University of Washington School of Dentistry, Seattle, WA, United States.
Thet Hnin SuDepartment of Periodontics, University of Washington School of Dentistry, Seattle, WA, United States.ORCID 0009-0007-2900-0695
Zoe Luderman MillerDepartment of Periodontics, University of Washington School of Dentistry, Seattle, WA, United States.
Alisa J KingSciences and Mathematics Division, School of Interdisciplinary Arts and Sciences, University of Washington Tacoma, Tacoma, WA, United States.
Joshua OrtizSciences and Mathematics Division, School of Interdisciplinary Arts and Sciences, University of Washington Tacoma, Tacoma, WA, United States.ORCID 0000-0003-1566-3344
Angel ReddySciences and Mathematics Division, School of Interdisciplinary Arts and Sciences, University of Washington Tacoma, Tacoma, WA, United States.ORCID 0009-0002-9924-7187
Sarah R AlaeiSciences and Mathematics Division, School of Interdisciplinary Arts and Sciences, University of Washington Tacoma, Tacoma, WA, United States.ORCID 0009-0007-3928-0336
Sumita JainDepartment of Periodontics, University of Washington School of Dentistry, Seattle, WA, United States.ORCID 0000-0003-1791-0089

Funding

Regulation and impact of lipid A modification in the pathogenesis of Porphyromonas gingivalisR01DE032027 · NIDCR · UNIVERSITY OF WASHINGTON · PI JAIN, SUMITA · 2022 to 2024
$1.1M
Elam M. and Georgina E. Hack Memorial Research FundNIDCR NIH HHS R01 DE032027NIH HHS R01 DE032027University of Washington Department of Periodontics
6 · The paper itself

Abstract

Porphyromonas gingivalis (Pg) is a prevalent pathogen that promotes human periodontal disease (PD) and exacerbates systemic comorbidities such as atherosclerosis, rheumatoid arthritis, and Alzheimer's disease. Pg produces nonphosphorylated tetra-acylated lipid A (NPLA) in its outer membrane (OM) that evades host Toll-like receptor 4 (TLR4), inflammasome pathways, and cationic peptides, enhancing bacterial survival. Here, we show that Pg also releases outer membrane vesicles (OMVs) that engage and divert host cell TLR4, inflammasome, and LL-37 responses away from the microbe. We determined that Pg OMVs are enriched for C4' monophosphoryl lipid A (C4'-MPLA), an established agonist for TLR4-TRIF-IFNβ and inflammasome-IL-1β responses. Comparisons of Pg 381 and Pg 33277 stationary phase cultures revealed higher OMV production by Pg 381, which correlates with its higher proinflammatory pathogenicity. The cationic peptide, polymyxin B (PMB), which selectively binds lipid A C4'-phosphate, reduces OMV-stimulated HEK cell TLR4 activation and THP-1 cell IL-1β production, confirming the proinflammatory role for OMV-C4'-MPLA. Similar to PMB, the host defense peptide, LL-37, inhibits OMV-C4'-MPLA-dependent HEK cell TLR4 activation. PMB and LL-37 also blocked OMV-C4'-MPLA-driven TLR4 activation in human umbilical vein endothelial cells. Finally, wild-type Pg-containing OM-NPLA is highly resistant to LL-37 antimicrobial activity, whereas the ΔlpxF mutant bacterium, retaining OM-C4'-MPLA, is killed by the peptide. In summary, Pg escapes host TLR4 signaling, inflammasome activation, and LL-37 interaction by retaining immunoevasive OM-NPLA. Moreover, Pg dispenses proinflammatory OMV-C4'-MPLA, which engages and redirects those host defenses. We suggest that OMV-C4'-MPLA triggers elevated IFNβ and IL-1β cytokines, which typify PD comorbidities, and drive PD-related alveolar bone loss.

Indexed as

Bacterial Outer MembraneBacteroidaceae InfectionsImmunity, InnateInflammationLipid APorphyromonas gingivalisAntimicrobial Cationic PeptidesCathelicidinsHumansInflammasomesInterleukin-1betaPolymyxin BToll-Like Receptor 4Antimicrobial Cationic PeptidesCathelicidinsInflammasomesInterleukin-1betaLipid Amonophosphoryl lipid APolymyxin BTLR4 protein, humanToll-Like Receptor 4C4′-monophosphorylated lipid AinflammasomeLL-37outer membrane vesiclesToll-like receptor 4

Identifiers

PMID40131356
PMCPMC12123218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.